Pen Injection Devices to 2024

Pen Injection Devices to 2024

  • June 2017 •
  • Report ID: 3620305
User-friendly syringe and injection device designs and the availability of an increasing number of drugs in prefilled insertable and disposable cartridges are propelling the growth of pen injection devices for self-administration. The cost of biologicals such as recombinant proteins has created interest in pen injectors to reduce cost and waste associated with the handling of vial-packaged drugs.

A second factor is the continued adoption of custom pen designs as a way of differentiating injectables developed for self-administration through product branding. These devices feature one or more user-friendly features to further the product’s desirability relative to competing options.

What You Will Learn
What injectable drugs are supplied in pen injection devices; what are the key market segments, market dynamics and market demographics?
What are the key therapeutic segments, demand drivers and commercial pen products?
What are the design factors, material selection issues, technologies and market development issues?
How big is the pen injection device market? How fast is it growing? What will it look like in 2024?
Who are the leading device and drug sector participants, their product development activities, business strategies, and corporate alliances and affiliations?
What is the importance of pharma-device alliances and design partnerships on pen injection device commercialization and market access?
What are the significant economic, technology, and regulatory factors affecting the market for pen injection devices?